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Most cancer immunotherapies under present investigation
are based on the belief that cytotoxic T cells are the most
important anti-tumoral immune cells, whereas intratu-
moral macrophages would rather play a protumoral role.
We have challenged this antagonistic point of view and
searched on the contrary for complementary contributions
provided by tumor-infiltrating T cells and macrophages,
reminiscent of those observed in anti-infectious responses.
We demonstrate that, in a model of therapeutic vaccina-
tion, cooperation between myeloid cells and T cells is
indeed required for tumor rejection. Vaccination elicited
an early rise of CD11b+ myeloid cells that preceded and
conditioned the intratumoral accumulation of CD8+
T cells. Conversely, CD8+ T cells and IFNg production
activate myeloid cells and were required for tumor regres-
sion. A 4-fold reduction of CD8+ T cell infiltrate in
CXCR3KO mice did not prevent tumor regression,
whereas a reduction of tumor-infiltrating myeloid cells sig-
nificantly interfered with vaccine efficiency. We show that
macrophages from regressing tumors can eliminate tumor
cells by TNFa release and phagocytosis. Altogether, our
data suggest new strategies to improve the efficiency of
cancer immunotherapies, by promoting intratumoral
cooperation between macrophages and T cells.
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